| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 119.42B | 122.14B | 120.64B | 117.90B | 98.17B | 84.50B |
| Gross Profit | 21.28B | 23.03B | 21.05B | 18.31B | 11.72B | 12.62B |
| EBITDA | 13.03B | 15.01B | 13.40B | 12.63B | 6.87B | 8.32B |
| Net Income | 3.58B | 10.96B | 3.96B | 5.04B | 2.11B | 2.10B |
Balance Sheet | ||||||
| Total Assets | 137.58B | 147.37B | 138.40B | 137.73B | 126.13B | 115.63B |
| Cash, Cash Equivalents and Short-Term Investments | 49.65B | 54.03B | 49.92B | 45.36B | 42.70B | 38.98B |
| Total Debt | 19.58B | 24.18B | 20.16B | 20.20B | 26.30B | 21.93B |
| Total Liabilities | 49.20B | 55.03B | 46.67B | 50.22B | 50.59B | 43.16B |
| Stockholders Equity | 84.84B | 87.89B | 87.94B | 84.54B | 72.91B | 68.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.84B | 5.61B | 10.54B | 226.00M | 370.00M |
| Operating Cash Flow | 0.00 | 12.21B | 9.24B | 14.88B | 5.45B | 4.16B |
| Investing Cash Flow | 0.00 | -856.00M | -4.34B | -5.16B | -4.68B | -4.97B |
| Financing Cash Flow | 0.00 | -9.72B | -2.88B | -9.40B | 1.28B | -897.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥554.02B | 9.48 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥1.09T | 10.11 | 9.11% | 1.60% | 13.08% | 78.00% | |
69 Neutral | ¥111.63B | 10.43 | ― | 5.78% | 1.24% | 186.45% | |
69 Neutral | ¥534.74B | 9.88 | 4.89% | 2.59% | 1.09% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥6.06B | 9.02 | ― | 2.64% | 19.30% | 56.43% | |
55 Neutral | ¥3.04B | 21.75 | ― | 3.03% | 2.78% | ― |